Cardiolipin (CL) synthase (Cls) is an enzyme crucial for synthesizing cardiolipin, an anionic phospholipid primarily located in the energy-transducing membranes of bacteria and the mitochondria of eukaryotes . In Escherichia coli, three Cls enzymes, ClsA, ClsB, and ClsC, catalyze the formation of CL from two phosphatidylglycerol (PG) molecules . Recombinant Salmonella choleraesuis Cls refers to the Cls enzyme produced using recombinant DNA technology in Salmonella choleraesuis, a Gram-negative bacterium .
CL is essential for various cellular functions, including the optimal activity of enzymes involved in mitochondrial energy metabolism . It stabilizes respiratory complexes, promotes the assembly of adenosine 5'-triphosphate synthase dimers, and maintains the curvature of mitochondrial cristae . In bacteria, CL is involved in cell division and DNA replication .
The E. coli genome encodes three cardiolipin synthases: ClsA, ClsB, and ClsC . A triple mutant lacking all three (clsA, clsB, and clsC) does not produce detectable CL, confirming that ClsC is essential for CL synthesis .
ClsC exhibits sequence homology to ClsA and ClsB and belongs to the phospholipase D superfamily . Unlike eukaryotic Cls enzymes, which use PG and CDP-diacylglycerol as substrates, ClsC, in conjunction with YmdB, utilizes phosphatidylethanolamine (PE) as the phosphatidyl donor to PG, representing a unique mode of CL synthesis .
ClsC functions in complex with YmdB, a protein containing a macro domain with ADP-ribose-binding potential . Co-expression of both proteins results in CL levels comparable to those achieved by ClsA or ClsB individually . YmdB enhances ClsC activity, and both genes are transcribed from the same polycistronic operon .
The ymdB-clsC operon is present in bacteria closely related to E. coli, such as Salmonella, Shigella, Cronobacter, Citrobacter, and Enterobacter .
Cardiolipin Synthase (CLS) and Phosphatidylglycerophosphate synthase (PGPS), which are involved in the biosynthesis of CL and PG, belong to CDP-alcohol phosphotransferase family .
Recombinant attenuated Salmonella strains are used as live vector vaccines . For example, a recombinant attenuated S. Choleraesuis strain, rSC0016, expressing the PlpE antigen of P. multocida, has been developed as a vaccine candidate . Oral inoculation of rSC0016(pS-PlpE) induces humoral, Th1, Th2, and mucosal immune responses in mice .
Recombinant S. Choleraesuis vaccine strains can be constructed to express various antigens, such as P42 or P97 from Mycoplasma hyopneumoniae . The expression of these antigens is confirmed by PCR amplification and double digestion of the host plasmid .
KEGG: sec:SCH_1735
Cardiolipin synthase (cls) is an enzyme responsible for synthesizing cardiolipin, an anionic phospholipid crucial for bacterial membrane integrity. In most bacteria, cardiolipin synthase catalyzes the condensation of two phosphatidylglycerol (PG) molecules to form cardiolipin (CL) . The presence of cardiolipin in bacterial membranes plays several critical roles:
In Salmonella and related enterobacteria, cardiolipin typically comprises 7-10% of total membrane phospholipids, with levels increasing during stationary growth phase .
The cls gene organization in Salmonella follows a pattern similar to other Gram-negative enterobacteria like E. coli and Shigella:
Most enterobacteria contain multiple CLS genes, with most species encoding at least 2 synthases
The primary cardiolipin synthase in Salmonella is encoded by the clsA gene (also simply designated cls in some literature)
Based on studies in related bacteria, Salmonella likely possesses homologs to E. coli's clsB and clsC genes, which provide complementary or conditional cardiolipin synthesis activity
ClsA is typically the major cardiolipin synthase during exponential growth, while ClsC contributes significantly during stationary phase
Research in S. flexneri has demonstrated that clsA deletion results in almost complete loss of cardiolipin during exponential growth, confirming its role as the primary synthase .
Based on the available sequence data and structural analysis of homologous proteins:
Full-length Salmonella choleraesuis cardiolipin synthase consists of 486 amino acids
The protein contains N-terminal transmembrane helical regions that anchor it to the inner membrane
The catalytic region includes two phospholipase D-like domains (PLD1 and PLD2)
His217 is likely the putative active-site nucleophile, based on homology to other cardiolipin synthases
The protein has multiple functional regions including:
The amino acid sequence of Salmonella choleraesuis cardiolipin synthase shows high conservation with other enterobacterial cls proteins, particularly those from S. typhimurium and S. heidelberg (>95% identity) .
Expression and purification of recombinant Salmonella cls typically follows this methodology:
Expression system: E. coli is the preferred heterologous expression host
Fusion tags: N-terminal His-tags are commonly used to facilitate purification
Storage buffer: Tris/PBS-based buffer with 50% glycerol at pH 8.0 is optimal for stability
Storage conditions: -20°C or -80°C for extended storage, with aliquoting to avoid freeze-thaw cycles
Working conditions: Stored aliquots can be maintained at 4°C for up to one week
Reconstitution: Protein is typically reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Biochemical characterization of cardiolipin synthases has historically been challenging due to difficulties in producing sufficient amounts of active, purified protein. Recent advances have improved purification strategies for enterobacterial cls enzymes .
Mutations in cardiolipin synthase can significantly alter membrane phospholipid composition with cascading effects on bacterial physiology:
Phospholipid balance: Deletion of clsA increases phosphatidylglycerol (PG) levels while decreasing cardiolipin content
Protein translocation: Reduced cardiolipin impairs translocation of proteins across the inner membrane
Stress responses: Cardiolipin depletion activates the Rcs envelope stress response pathway
Motility impacts: Reduced cardiolipin leads to cells lacking assembled flagella, affecting motility and surface attachment
Biofilm formation: Cardiolipin deficiency impairs the earliest stages of biofilm formation, particularly initial attachment
Virulence effects: In S. flexneri, cardiolipin synthesis is required for effective plaque formation, with clsA mutants forming only pinpoint plaques
Interestingly, some mutations in cardiolipin synthase, particularly those near the active site (e.g., H215R and R218Q in Enterococcus), can increase enzyme activity and are associated with antimicrobial resistance .
Several complementary approaches can be used to assess cardiolipin synthase activity:
Phospholipid Composition Analysis:
Bligh-Dyer phospholipid extraction followed by thin-layer chromatography (TLC)
Quantification of relative phospholipid proportions (PE:PG:CL ratios)
Genetic Manipulation Approaches:
Construction of cls gene deletion mutants (single and combinatorial deletions)
Site-directed mutagenesis of key residues in the catalytic domain
Functional Assays:
Biochemical Characterization:
Cardiolipin shows distinct distribution patterns between bacterial membrane compartments with specific functional implications:
Synthesis location: Cardiolipin is synthesized at the inner membrane where cardiolipin synthase is anchored
Transport mechanism: Transport of cardiolipin to the outer membrane requires the PbgA (YejM) phospholipid transporter
Inner membrane functions: In the inner membrane, cardiolipin:
Outer membrane functions: In the outer membrane, cardiolipin:
Research in S. flexneri demonstrates that both cardiolipin synthesis (via ClsA) and transport to the outer membrane (via PbgA) are essential for virulence, with pbgA mutants being unable to form plaques .
Alterations in cardiolipin synthesis can significantly impact antibiotic susceptibility:
Daptomycin resistance: In enterococci, mutations in cardiolipin synthase (particularly in the catalytic region) are associated with daptomycin resistance
Increased enzyme activity: Some resistance-associated mutations (H215R, R218Q) increase cardiolipin synthase activity rather than decrease it
Membrane charge: Changes in cardiolipin content alter membrane surface charge, potentially affecting interactions with cationic antimicrobial peptides
Membrane fluidity: Altered cardiolipin levels modify membrane fluidity and permeability, potentially reducing antibiotic penetration
Bacterial stress responses: Cardiolipin-mediated changes in envelope stress responses may upregulate additional resistance mechanisms
These findings suggest that cardiolipin synthase could be both a resistance determinant and a potential drug target .
Environmental conditions significantly influence cardiolipin synthesis through multiple regulatory mechanisms:
Osmotic stress response: Osmotic stress induces 2-3 fold increases in cls transcription in both E. coli and B. subtilis
Growth phase regulation: Cardiolipin levels increase from ~7% in exponential phase to ~10% in stationary phase in S. flexneri
Differential synthase expression: While ClsA is the primary synthase during exponential growth, ClsC becomes more active during stationary phase in S. flexneri
Intracellular environment effects: Both clsB and clsC show approximately 10-fold induction in intracellular bacteria
Transcriptional control: Growth phase transitions trigger transcriptional changes, with cls expression increasing 2.5-fold as E. coli enters stationary phase even in low osmolality media
These regulatory mechanisms allow bacteria to adapt their membrane composition in response to changing environmental conditions, potentially enhancing survival under stress.
To differentiate the roles of multiple cardiolipin synthase homologs, researchers can employ these strategies:
Genetic Approaches:
Generation of single, double, and triple cls gene deletion mutants
Growth phase-specific phenotypic analysis of different mutants
Complementation studies with plasmid-expressed individual cls genes
Expression Analysis:
Quantification of cls gene expression under different growth conditions
Measurement of cls gene induction during environmental stress
Determination of intracellular expression levels of different cls genes
Biochemical Characterization:
Comparison of substrate preferences between different purified cls enzymes
Analysis of enzyme kinetics under various physiological conditions
Structural studies to identify unique features of each homolog
Phenotypic Assessment:
Phospholipid composition analysis of single and combinatorial mutants
Virulence assays to determine the contribution of each synthase to pathogenesis
Stress response evaluations to identify condition-specific roles
Cardiolipin deficiency triggers specific stress response pathways with widespread physiological consequences:
Rcs pathway activation: Reduced cardiolipin activates the Regulation of Colanic Acid Synthesis (Rcs) envelope stress response
RcsF signaling: Cardiolipin depletion likely activates Rcs through the outer membrane lipoprotein RcsF
Mechanistic basis: Impaired protein translocation across the inner membrane appears to be the molecular trigger connecting cardiolipin deficiency to Rcs activation
Flagellar repression: Activated Rcs pathway represses flagellar production, disrupting motility and initial biofilm attachment
Colanic acid production: Rcs activation triggers production of colanic acid, altering surface properties
Biofilm formation: The combined effects lead to significant reductions in biofilm growth and development
This cascade demonstrates how alterations in membrane phospholipid composition can trigger specific stress responses that alter multiple aspects of bacterial physiology and adaptation.
Several technical challenges complicate the development of high-throughput screening for cardiolipin synthase inhibitors:
Protein stability: Difficulties in producing stable, highly purified cardiolipin synthase for in vitro assays
Membrane association: The transmembrane domains of cls proteins complicate expression and purification strategies
Assay design: Developing sensitive, reliable assays for cardiolipin formation that are amenable to high-throughput formats
Substrate delivery: Ensuring proper presentation of lipid substrates to the enzyme in screening assays
Specificity determination: Differentiating between direct enzyme inhibition and non-specific membrane disruption
Penetration barriers: Ensuring potential inhibitors can cross bacterial membranes to reach their target
Species selectivity: Developing compounds that target bacterial cls without affecting eukaryotic cardiolipin synthesis
Despite these challenges, the importance of cardiolipin in bacterial physiology and virulence makes cls an attractive potential antimicrobial target.
| Species | Primary CL Synthase | Size (amino acids) | Active Site Residues | Substrate Preference | Cellular Localization |
|---|---|---|---|---|---|
| Salmonella choleraesuis | ClsA | 486 | His217 (predicted) | PG + PG | Inner membrane |
| Escherichia coli | ClsA | 486 | His224 | PG + PG | Inner membrane |
| Shigella flexneri | ClsA | 486 | His224 (predicted) | PG + PG | Inner membrane |
| Enterococcus faecium | Cls | ~430 | His215 | PG + PG | Inner membrane |
| Growth Phase | Cardiolipin Level in S. flexneri | Primary Active Synthase | Transcriptional Regulation | PG:PE:CL Ratio |
|---|---|---|---|---|
| Exponential | ~7% of total phospholipids | ClsA | Basal expression | High PG, Low CL |
| Stationary | ~10% of total phospholipids | ClsA, ClsC | Increased cls expression | Lower PG, Higher CL |
| Intracellular | Not determined | ClsA, increased ClsB/C expression | ~10-fold induction of clsB/C | Not determined |